AstraZeneca PLC ADRhedged

AstraZeneca PLC ADRhedged is offered by ADRhedged, a leading player in the field of passive investments.

The total expense ratio of AstraZeneca PLC ADRhedged is 0.19%, which means that investors pay 19 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, AstraZeneca PLC ADRhedged does not comply with the EU UCITS investor protection directives.

AstraZeneca PLC ADRhedged tracks the performance of the AstraZeneca PLC - Benchmark Price Return.

The current average trading volume of AstraZeneca PLC ADRhedged is 4,739.07.

AstraZeneca PLC ADRhedged is domiciled in US.

The fund was launched on 10/1/2024.

The AstraZeneca PLC ADRhedged mainly invests in Healthcare companies.

The NAV of AstraZeneca PLC ADRhedged amounts to 54.92 M USD.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.